TGM2 and irritable bowel syndrome: A meta-analysis of studies comparing the prevalence of celiac disease between patients with IBS and controls showed that pooled prevalence of IgA antibodies to tissue transglutaminase in patients with IBS was 5.7% and the odds ratio for having biopsy proven celiac disease was 4.5 (32).